Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,545 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,124
Recruiting: 1,217
Ph III recruiting: 128
Growth YoY: +13.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (886)

clinicaltrialsPublishedShowing 801–850 of 1,111 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07097064	Evaluation of the Stereotactic MR-guided Adaptive Radiotherapy for Locally Advanced Pancreatic Cancers(RAIPANC)	not yet recruiting	Phase 2	160	Institut du Cancer de Montpellier - Val d'AurelleOTHER	1	Jul 31, 2025	clinicaltrials
NCT06105021	Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor	active not recruiting	Phase 1 / Phase 2	100	Affini-T Therapeutics, Inc.INDUSTRY